TG Therapeutics | Betriebsaufwand



Operating Expenses Veränderung Datum
AbbVie USD 9.71B 96M 2025-06
Alaunos Therapeutics USD 759K 391K 2024-12
Amgen USD 6.52B 337M 2025-06
Ardelyx USD 108M 12M 2024-12
Arrowhead Research USD 193.32M 31.81M 2025-06
Bayer EUR 10.73B 688M 2025-06
Biogen USD 1.79B 326.1M 2025-06
Corcept Therapeutics USD 167.76M 13.96M 2025-06
Dynavax Technologies USD 81.01M 10.78M 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
J&J USD 16.8B 8.54B 2025-06
Novartis USD 9.97B 1.02B 2025-06
PTC Therapeutics USD 213.73M 7.86M 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
TG Therapeutics USD 106.3M 5.93M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06


TG Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.